Question · asked by 1 review

Peripartum/postnatal prophylaxis (caesarean): heparin (LMWH or UFH) vs no treatment/placebo: Maternal death

Population
women giving birth by elective or emergency caesarean (elective only (1 trial), emergency or elective (4 trials))
Intervention
Peripartum/postnatal prophylaxis (caesarean): heparin (LMWH or UFH)
Comparison
no treatment/placebo
Outcome
Maternal death

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Peripartum/postnatal prophylaxis (caesarean): heparin (LMWH or UFH) vs no treatment/placebo
Maternal death (timing of assessment unclear) · women giving birth by elective or emergency caesarean (elective only (1 trial), emergency or elective (4 trials))
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period (2021) · Cochrane Headline outcomes only
no estimate extracted1 study · 300 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
2021 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.